Develop T2D Patient-Centered Treatment Suggestion Rule using EMR data
Develop T2D Patient-Centered Treatment Suggestion Rule using EMR data
批准号:
9330849
负责人:
Jin Zhou
金额:
$13.07万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-08-11 至 2020-05-31
关键词:
AdoptedAdverse effectsAdverse eventAffectAgonistAlgorithmsAmericanAmputationBig DataBlindnessCaringCharacteristicsChronicCombination MedicationComplementComplexComputerized Medical RecordDataData AnalysesDatabasesDecision MakingDiabetes MellitusDiagnosticDietEffectivenessExpert OpinionFailureGLP-I receptorGlucoseGuidelinesHealth PersonnelHealthcare SystemsHeterogeneityIncidenceIndividualInjectableInsulinLifeLife StyleMedicalMedicineMentorsMethodsModelingMorbidity - disease rateNon-Insulin-Dependent Diabetes MellitusObservational StudyOralOutcomeOutcomes ResearchPathologyPathway interactionsPatient-Focused OutcomesPatientsPatternPerformancePharmaceutical PreparationsPhysiciansPublishingRandomized Clinical TrialsRecommendationRecordsRegimenResearchRiskSchemeSocietiesStandardizationSubgroupSuggestionTestingToxic effectTreatment EffectivenessTreatment ProtocolsUnited StatesUnited States Department of Veterans AffairsUpdateValidationbasal insulinbaseclinical practicecohortcostdesigndiabetes managementeffectiveness measurefollow-uphealth care service utilizationinclusion criteriaindividualized medicinemedical specialtiesmortalitypatient orientedpersonalized carepersonalized medicineprogramsresponsestandard caretooltreatment centertreatment effecttreatment responseuser friendly software
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Develop T2D Patient-Centered Treatment Suggestion Rule using EMR data
In clinical practice, physicians and health care providers often follow the treatment guidance based on
published research and experts' opinions. The American Diabetes Association (ADA) annually publishes
updated recommendations for Type 2 Diabetes (T2D) management. Although the standardized diabetes
management approach has resulted in substantial improvement in overall diabetes care, different patients
often respond to treatments differently (treatment heterogeneity effects). This proposal aims to develop
methods to facilitate personalized treatment recommendations using information from electronic medical
records (EMR) for T2D. We will first evaluate the real world effectiveness of different treatments when
diabetes patients follow the treatment guidance. We will then assess the treatment differences, identify the
baseline information that has predictive ability for the treatment differences, and develop treatment
recommendation rules for a single individual or subgroups of individuals. As EMR is a type of observational
study, the propensity score matching method will be adopted to determine causal relationships. Finally, we will
use cross validation and independent data to validate our results. Methods proposed in this research will be
implemented in an efficient and user-friendly software package to further facilitate easy patient-centered
treatment decision-making. The proposed method uses information from EMR data, which contains
comprehensive baseline information for approximately 20 million US patients and “real world” drug
effectiveness. Therefore our method bridges the gap of using “big and generalizable” data for patient-centered
outcomes research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金